Yeda Research and Development Company Ltd. is the commercial arm of the Weizmann Institute of Science. Yeda holds an exclusive agreement with the Weizmann Institute to commercialize the unique intellectual property developed by the scientists. The income generated serves to support further basic research and science education. - Identify and assess research projects with commercial potential. - Protect the intellectual property of the Institute and its scientists. - Create business relationships and license the Institute’s inventions and technologies to the industry. - Channel funding from industry to research projects. For further information please contact Tamir Huberman, CIO and Head of Marketing

ERYTech Pharma SA is a biopharmaceutical company, which develops medical products. The firm conducts research and development of innovative red blood cell-based therapeutics for cancer and orphan diseases. The company was founded by Pierre-Olivier Goineau and Yann Godfrin on November 22, 2004 and is headquartered in Lyon, France.

Central Iowa Health Systems, part of Iowa Health System, is an American company located in Des Moines, IA. The firm provides health care services.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.

Cytovac is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies with a primary focus towards orphan diseases. The company is a leader in the rapidly developing field of individualized cell-based therapies for solid tumors, and is using the ALECSAT platform to generate best-in- class therapeutics to treat cancer with a high unmet medical need.

JW CreaGene, Inc. engages in the manufacture of pharmaceutical products. The company was founded in 1998, and is headquartered in Seongnam-si, South Korea.

VAXON Biotech SA develops therapeutic vaccines for the treatment of cancers. It offers treatment for lung, gastric, prostate, breast, renal, liver, and colorectal cancers, using its proprietary technology of optimized cryptic peptides. The firm also provides research and development services. The company was founded by Konstantinos Kosmatopoulos in 2004 and is headquartered in Paris, France.

Changchun BCHT Biotechnology Co. engages in the research and development, production and sale of human vaccines. It specializes in prevention and treatment of infectious diseases. Its products include chickenpox vaccine, rabies vaccine, and freeze-dried nasal spray flu vaccine. The company was founded on March 4, 2004 and is headquartered in Changchun, China.

The Institute for Biomathematics and Biometry conducts fundamental research in areas including Epidemiology, Analysis of Complex Experimental Data, Analysis of Environmental Chemicals, Machine Learning, Bacterial Communication Processes in the Rhizosphere, the Regulation Pathway of NF-κB and Coagulation Cascades.

Specializes in biopharmaceutical products with focus in immunotherapy for the treatment of cancer

Boehringer Ingelheim International GmbH manufactures pharmaceutical prodcuts. It offers human and animal health products. The company was founded by Albert Boehringer in 1885 and is headquartered in Ingelheim, Germany.

Takis Srl is a private company headquartered in Castel Romano, Italy, that operates as biotechnology company that engages in drug discovery and therapeutic cancer vaccines development. The firm was founded by Luigi Aurisicchio, who is the current CEO of the firm.\nThe company says this about itself: Takis is a biotechnology company created by a group of scientists formerly from Merck Research Laboratories (MRL) and it is located in Rome (Italy). The group has more than 15 years of experience and proven expertise in drug discovery in Oncology and is recognized for the design and implementation of a number of innovative technologies, including that of DNA gene therapy. One of Takis’s core assets is its experience with electroporation, a technology that can be used for a variety of clinically useful applications, from vaccine development to somatic gene therapy. Takis’ pipeline includes four cancer vaccine candidates based on this technology. Takis is also actively involved in the generation of humanized monoclonal antibodies for use in oncology and infectious diseases, including COVID-19.

Menarini International Operations Luxembourg SA is a private company headquartered in Luxembourg. The firm manufactures and wholesales pharmaceutical products.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Saitama Medical University (埼玉医科大学 Saitama Ika Daigaku) is a private university at Moroyama, Saitama, Japan. The predecessor of the school, the Moro Hospital, was founded in 1892, and it was chartered as a university in 1972.

immatics is a biopharmaceutical company focused on the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors. The company's customized Adoptive Cell Therapies (ACTengine) and antibody-like TCR Bispecifics are the two main product classes in the pipeline (TCER). With a focus on particularly difficult-to-treat solid malignancies, each therapy modality has unique characteristics to create the desired therapeutic impact for patients at various disease stages and with various types of tumors. immatics biotechnologies was established in 2000 by Hans Rammensee, Harpreet Singh, and Steffen Walter in Tübingen, Baden-Wurttemberg.

Guangzhou Zhiyuan Biotechnology Co., Ltd., established on 2017-08-02, Business scope includes technical services,technology development,technical consulting,Technology Exchange,technology transfer,Technology Promotion;Remote Health Management Services;Health Consulting Services(Does not include medical services);Cosmetics Retail;Cosmetics Wholesale;Household Appliances Retail;internet sales(Except for products that require a license for sale);Sales of Class II Medical Devices;Sales of Class I Medical Devices;Internet Information Service for Medical Devices;Class III medical device business;Production of hygiene products and single-use medical products;Drug Wholesale;Drug internet information service;Drug retail